Angioplasty

ESC 2023

ESC 2023 | ILUMIEN IV: What Is the Benefit of OCT?

Researchers conducted a randomized study that included a total of 1233 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) guided by optical coherence tomography (OCT) and 1254 patients who underwent the same procedure but were guided by angiography. The latter had complex lesions. The initial groups were similar. The average age was 65 years, most<a href="https://solaci.org/en/2023/08/29/esc-2023-ilumien-iv-what-is-the-benefit-of-oct/" title="Read more" >...</a>

SOLACI-SBHCI 2023 Scientific Coverage &#8211; Day 3

The third day of the Congress started at the Copacabana Arena with the International Live Case held at Nanjing First Hospital, Nanjing, China, which showcased a successful and illustrative step-by-step Transcatheter Coronary Intervention (TCI) angioplasty with circulatory support and optimized results using Intravascular Ultrasound (IVUS) applicability. Following that, Dr. Fei Ye presented Intravascular Imaging and<a href="https://solaci.org/en/2023/08/05/solaci-sbhci-2023-scientific-coverage-day-3/" title="Read more" >...</a>

SOLACI Research Registries were presented at the SOLACI-SBHCI 2023 Congress

The area of records within SOLACI &#8211; SOLACI Research &#8211; continues to grow and share the results of its investigations with the entire Latin American interventional community. In this case, a dedicated session was held during the SOLACI-SBHCI 2023 Congress to present the data from the SOLACI records and to discuss the challenges of carrying<a href="https://solaci.org/en/2023/08/04/solaci-research-registries-were-presented-at-the-solaci-sbhci-2023-congress/" title="Read more" >...</a>

SOLACI/SBHCI 2023: Scientific Coverage &#8211; Day 2

The second day of the SOLACI/SBHCI 2023 Congress, the largest interventional cardiology meeting in Latin America, organized by the Latin American Society of Interventional Cardiology (SOLACI) and the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), held in Rio de Janeiro, featured various national and international guests, along with important sessions on the main topics<a href="https://solaci.org/en/2023/08/03/solaci-sbhci-2023-scientific-coverage-day-2/" title="Read more" >...</a>

Device Effectiveness for Femoropopliteal Artery Disease Treatment: Analysis of K-VIS ELLA Registry

Endovascular treatment of lesions in femoropopliteal territory (FPA) has become the main therapeutic option, seeing as it is less invasive and has faster recovery. It has used different devices, such as conventional bare metal stents (BMS), balloon angioplasty (POBA), and drug coated balloons (DCB), as well as drug eluting stents (DES). However, real world data<a href="https://solaci.org/en/2023/07/24/device-effectiveness-for-femoropopliteal-artery-disease-treatment-analysis-of-k-vis-ella-registry/" title="Read more" >...</a>

Abbott Vascular suspendió la venta de Absorb en todos los países

ABSORB IV Improving Bioresorbable Scaffolds: A Long Road

5-year followup of bioresorbable scaffolds in selected and better prepared lesions (ABSORB IV).&nbsp; Historically, when comparing previously used therapies, such as conventional balloon angioplasty (BA) against bare metal stent (BMS) and later against drug eluting stent (DES) implantation, we see significantly improved outcomes. These advances have shown reduced recoil and more effective restenosis inhibition, compared<a href="https://solaci.org/en/2023/07/19/absorb-iv-improving-bioresorbable-scaffolds-a-long-road/" title="Read more" >...</a>

MIL Train More MIL: Day 3

&#x25b6; We continue to share the experience MIL Training More MIL SOLACI, our training program on structural heart disease for Latin American Women Interventionists. &#x1f449; The third day of activities was carried out at the Italian Hospital in Buenos Aires. &#x2705; We had an inspiring scientific agenda: &#x1f449; 20 years of TAVR, where our<a href="https://solaci.org/en/2023/06/29/mil-train-more-mil-day-3/" title="Read more" >...</a>

BASIL-2: Revascularization of Infra-Popliteal Territory in Patients with Critical Lower Limb Ischemia

Results of infrapopliteal territory revascularization in critical limb ischemia. Compared against the general population, patients suffering from critical lower limb ischemia (CLI) not only experience seriously limited quality of life, but also face a significant higher risk of death and amputation.&nbsp; Specifically, the optimal treatment for these patients remains uncertain. This uncertainty was sparked by<a href="https://solaci.org/en/2023/06/22/basil-2-revascularization-of-infra-popliteal-territory-in-patients-with-critical-lower-limb-ischemia/" title="Read more" >...</a>

Resultados a 2 años de los stents liberadores de Zotarolimus vs stents libres de polímero liberadores de Biolimus. ¿Son seguros en pacientes con alto riesgo de sangrado?

Intrastent Restenosis in Ostial Lesions in the Right Coronary Artery: Predictors of an Unfavorable Location

Predictors of intrastent restenosis in the right coronary artery ostium. The ostium of the right coronary artery (RCA) presents certain histological aspects. Atherosclerotic and fibrotic plaques in this area contain an abundance of smooth muscle, collagen, and a certain degree of calcification, along with thicker adventitia. Additionally, it has certain anatomical aspects such as poor<a href="https://solaci.org/en/2023/06/16/intrastent-restenosis-in-ostial-lesions-in-the-right-coronary-artery-predictors-of-an-unfavorable-location/" title="Read more" >...</a>

TAVI: Balón expandible o autoexpandible ¿Cuál es la respuesta?

TAVR: Does HALT Affect Follow-Up?

Transcatheter aortic valve replacement (TAVR) in low-risk patients has been shown to be superior or noninferior in randomized studies, but the presence of valvular thrombosis, in its different forms, has not been well analyzed, nor is there much information on its impact on evolution. Researchers conducted an analysis of the LTR study that included 200<a href="https://solaci.org/en/2023/06/07/tavr-does-halt-affect-follow-up/" title="Read more" >...</a>

Top